Swiss group Bellevue taps growing demand for PE with boutique buy

The Switzerland-listed firm wants to broaden its biotech and life sciences-focused remit to include mid-market investments in Germany, Switzerland and Austria.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this